US Stock IR Daily – October 13, 2026 (8 reports)

• UnitedHealth Group Incorporated filed a Form 8-K on October 13, 2026.
• The Form 8-K reported the issuance of a press release announcing its third-quarter 2026 results.
• A copy of the press release (Exhibit 99.1) and a hyperlinked PDF document (Exhibit 99.2) are furnished as exhibits to the report.
• The report was signed on October 13, 2026, by Kuai H. Leong, Senior Deputy General Counsel and Deputy Corporate Secretary of the company.

UnitedHealth’s filing of a Form 8-K on October 13, 2026, indicates the official announcement of its third-quarter 2026 financial results. This regulatory filing is a standard procedure for companies to disclose significant events, such as quarterly earnings. Investors typically refer to the accompanying press release and PDF document for detailed financial performance metrics, which could provide insights into the company’s operational and financial health.

• JPMorgan Chase & Co. reported its 2026 third-quarter results on October 13, 2026.
• Net income for the third quarter of 2026 was $15.3 billion.
• Earnings per share (EPS) for the third quarter of 2026 were $5.57.
• These figures represent an increase compared to the third quarter of 2025, which saw net income of $14.4 billion and EPS of $5.07.

JPMorgan Chase’s latest quarterly earnings report indicates an increase in both net income and earnings per share compared to the same period last year. This performance may suggest a continued strong financial position for the firm. Investors could interpret these results as a positive sign regarding the company’s operational strength within the current economic environment.

• Wells Fargo & Company issued a news release on October 13, 2026, concerning its results of operations and financial condition for the quarter ended September 30, 2026.
• The company also posted its “3Q26 Quarterly Supplement” on its website, providing additional information about its financial results for the quarter ended September 30, 2026.
• These materials are incorporated by reference into Item 2.02 of the Form 8-K.
• On October 13, 2026, the company intends to host a live conference call, also available by webcast, to discuss its third-quarter 2026 financial results and other related matters.
• In connection with the conference call, presentation materials containing historical and forward-looking information have been posted on the company’s website.

Wells Fargo’s release of its Q3 2026 results provides the market with current financial data. The news release, supplemental materials, and upcoming conference call offer investors a comprehensive view into the company’s performance for the quarter ended September 30, 2026. This information could be instrumental in assessing the company’s operational health and future outlook, which is typically of interest to investors.

• Emerson Electric Co. announced a change in its accounting method for actuarial gains and losses associated with its defined benefit pension and other postretirement benefit plans, effective for the fiscal year ended September 30, 2026.
• The new method, referred to as mark-to-market accounting, will recognize actuarial gains and losses in earnings in the period in which they arise.
• Historically, Emerson recognized these amounts in accumulated other comprehensive income and amortized a portion into net periodic benefit cost in subsequent periods.
• Beginning in the fourth quarter of fiscal 2026, the Company will recognize the annual mark-to-market adjustment in the fourth quarter based on the plans’ September 30 annual measurement date.
• The Company expects to record a pretax gain of less than $5 million for the mark-to-market adjustment in the fourth quarter of fiscal 2026, based on current actuarial assumptions and estimated plan asset returns; actual results could differ from preliminary estimates.
• This annual mark-to-market adjustment will be excluded from adjusted earnings per share due to its significant variability and lack of indication of underlying operating performance.

Emerson’s adoption of mark-to-market accounting for pension and postretirement benefit plans may suggest a move towards greater transparency in its financial reporting, aligning reported earnings more closely with current economic conditions. While the immediate impact on reported pretax gain for Q4 FY2026 is projected to be minor, the exclusion of this adjustment from adjusted EPS indicates the company’s intent to differentiate core operating performance from market-driven actuarial fluctuations. Investors may find it worthwhile to monitor how this change affects the volatility of reported earnings and the company’s overall financial narrative in future periods.

• The Goldman Sachs Group, Inc. reported its earnings for the third quarter ended September 30, 2026.
• A press release containing this financial information was attached as Exhibit 99.1 to the Form 8-K, dated October 13, 2026.
• A conference call to discuss the firm’s financial results, outlook, and related matters was scheduled for October 13, 2026, at 9:30 a.m. (ET).
• The presentation for the aforementioned conference call was attached as Exhibit 99.2 to the Form 8-K.

Goldman Sachs has released its latest quarterly earnings, providing insights into its operational performance for the period. Investors may find the detailed financial results and the subsequent conference call commentary crucial for understanding the firm’s current standing and future outlook within the financial services sector. Analyzing these materials in the context of broader economic conditions could offer valuable perspectives on the company’s strategic direction and its ability to navigate market challenges.

• Johnson & Johnson filed a Form 8-K on October 13, 2026.
• The Form 8-K includes a press release (Exhibit 99.1) announcing the company’s sales and earnings for the third quarter ended September 27, 2026.
• Unaudited Comparative Supplementary Sales Data and Condensed Consolidated Statement of Earnings for the fiscal third quarter and nine months (Exhibit 99.2) were also disclosed.

This Form 8-K filing from Johnson & Johnson formally announces the company’s financial results for the third quarter of 2026. The included press release and supplementary data are key documents for investors to review the latest performance metrics. This release provides an official update on sales and earnings, which may inform perspectives on the company’s operational and financial health.

• The Procter & Gamble Company announced a quarterly dividend of $1.0885 per share.
• This dividend is payable on or after November 16, 2026.
• The dividend is for Common Stock shareholders of record at the close of business on October 23, 2026, and Series A and Series B ESOP Convertible Class A Preferred Stock shareholders of record at the start of business on October 23, 2026.
• According to preliminary voting results, the Company’s twelve Director nominees were elected to the Board of Directors at the Annual Meeting of Shareholders.

This announcement indicates Procter & Gamble’s continued commitment to shareholder returns through its regular dividend program. The declaration of a quarterly dividend is a key aspect for investors focused on income generation. Furthermore, the election of all director nominees suggests stability in the company’s governance and leadership structure, which can be viewed positively by the market.

• Citigroup Inc. announced its results for the quarter ended September 30, 2026, on October 13, 2026.
• The announcement was made via a Form 8-K filing with the U.S. Securities and Exchange Commission (SEC).
• The related press release is filed as Exhibit 99.1, and the Quarterly Financial Data Supplement is furnished as Exhibit 99.2.
• The “CEO Commentary” quotation within Exhibit 99.1 is not deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934.
• The Quarterly Financial Data Supplement (Exhibit 99.2) is also not deemed “filed” for purposes of Section 18 of the Act.

Citigroup Inc.’s announcement of its latest quarterly results provides crucial insights into the company’s financial health and operational performance. The Form 8-K filing, along with its exhibits, offers a comprehensive view for investors to assess the company’s financial trends and strategic direction. It is worth noting that certain sections, specifically the “CEO Commentary” and the Quarterly Financial Data Supplement, are distinguished in their legal filing status under the Securities Exchange Act.